Until June, 2012, Andrew was Managing Director and U.S. Head of OTC Derivatives Client Clearing for Morgan Stanley. In this role, Andrew reorganized and managed a business encompassing sales, financial planning and analysis, product development, on-boarding, and client service functions. Previously, Andrew managed for the Federal Reserve Bank of New York ("FRBNY") the $1.25 Trillion Agency MBS Purchase Program (the centerpiece of "QE1"). In this role, Andrew managed the program's portfolio design and trading strategy, as well as the creation of a permanent, in-house Federal Reserve MBS business platform, encompassing front, middle and back office components. By way of additional professional background, Andrew was previously a Senior Vice President at RBS Greenwich Capital and co-head of the Transaction Advisory Group, specializing in the Basel II Capital Rules. Prior to RBS, he was an Examining Officer in the FRBNY's Bank Supervision Group, leading a Market and Liquidity analytics team assessing financial risk exposures of large U.S. financial institutions. Andrew began his career at the FRBNY as a lawyer supporting various business lines.
Andrew has a J.D. and M.B.A. from Columbia University and a B.S.F.S degree in International Relations with a Certificate in Latin American Economic Development from the Walsh School of Foreign Service at Georgetown University. Additionally, he has a "Certificate d'Etudes Politiques" from the Institut d'Etudes Politiques de Paris ("Sciences-Po").
AREAS OF RESEARCH:
The Federal Reserve System, The Dodd Frank Legislation, Global Financial Crisis
Link to Mr. Huszar's Involvement in 2014's MQF Summit